DexCom (DXCM) announced a $750 million share repurchase program in conjunction with first quarter results. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on DXCM: DexCom reports Q1 adjusted EPS 32c, consensus 33c DexCom options imply 8.6% move in share price post-earnings Is DXCM a Buy, Before Earnings? ISRG, LLY, or DXCM: Which “Strong Buy” Healthcare Stock Has the Highest Upside Potential? DexCom price target lowered to $100 from $115 at RBC Capital Disclaimer & DisclosureReport an Issue
